Review
Accepted on 17 Nov 2025
Structural and dynamic properties of IL1 receptors
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
Type at least 3 characters
1,265 articles
Review
Accepted on 17 Nov 2025
The role of interleukin-37 and interleukin-38 in the development and remission of autism spectrum disorder: A comprehensive review of neuroinflammatory mechanisms and potential therapeutic implications
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
Original Research
Published on 17 Nov 2025
SPHK1-mediated M2 macrophage polarization drives TGF-β1-dependent thrombus fibrosis
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1681485
- 273 views
Review
Published on 17 Nov 2025
The pivotal role of cytokines in liver disease pathogenesis and therapeutic potential
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1694582
- 434 views
Review
Accepted on 14 Nov 2025
Interleukin-32: A Pandora's box in human immunodeficiency virus infection
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
- 125 views
Original Research
Accepted on 14 Nov 2025
Serum Profiling of uPA, PAI-1, and suPAR in Systemic Sclerosis: A Preliminary Study on Analytical Aspects and Associations with Microvascular and Fibrotic Manifestations
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
Original Research
Published on 14 Nov 2025
Human spinal enthesis comparative biology of IL-17F and IL-17A reveals greater T-cell IL-17F induction and IL-23 regulation
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1658325
- 1,094 views
Editorial
Published on 13 Nov 2025
Editorial: Cytokines, and biomarkers involved in the immunomodulation of pediatric cancers
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1713006
- 715 views
Original Research
Accepted on 10 Nov 2025
CXCL9 and CXCL10 support the exacerbated humoral response in recovered COVID-19 patients who developed acute respiratory distress syndrome by promoting plasma cell differentiation, whereas CXCL9 also induces CD40L and CXCR3 upregulation on T helper cells
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
Review
Accepted on 07 Nov 2025
Metabolic Crossroads in Insulin Resistance: Exploring Lipid Dysregulation and Inflammation
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
- 140 views
Original Research
Published on 07 Nov 2025
Reciprocal activation between M1 macrophages and trophoblasts through CXCL9/STAT1/ZEB1/CCL2 axis promotes recurrent spontaneous abortion
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1629370
- 448 views
Mini Review
Published on 07 Nov 2025
Cytokine networks and therapeutic advances in systemic lupus erythematosus
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1680418
- 675 views
Original Research
Published on 06 Nov 2025
Interleukin-6 levels and their haplotypes are associated with serological autoantibodies status and clinical activity in rheumatoid arthritis
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1679644
- 792 views
Review
Published on 05 Nov 2025
Cytokines in sepsis: a critical review of the literature on systemic inflammation and multiple organ dysfunction
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1682306
- 1,137 views
Correction
Accepted on 04 Nov 2025
Mechanistic insights into IL-1β-mediated progression of tendinopathy
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
- 118 views
Original Research
Published on 04 Nov 2025
AIMing for survival: The impact of the free and total AIM concentration in septic patients
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1685119
- 520 views